{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:43:11Z","timestamp":1781826191541,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytical Biochemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ab.2021.114478","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T16:33:44Z","timestamp":1637339624000},"page":"114478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Saul Brusilow: Understanding and treating diseases of ammonia toxicity"],"prefix":"10.1016","volume":"636","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3241-7719","authenticated-orcid":false,"given":"William S.A.","family":"Brusilow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ab.2021.114478_bib1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJM197505222922101","article-title":"Treatment of carbamyl phosphate synthetase deficiency with keto analogues of essential amino acids","volume":"292","author":"Batshaw","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2021.114478_bib2","first-page":"227","article-title":"Long-term management of a case of carbamyl phosphate synthetase deficiency using ketanalogues and hydroxyanalogues of essential amino acids","volume":"58","author":"Batshaw","year":"1976","journal-title":"Pediatrics"},{"key":"10.1016\/j.ab.2021.114478_bib3","first-page":"65","article-title":"Use of keto acids in inborn errors of urea synthesis","volume":"8","author":"Brusilow","year":"1979","journal-title":"Curr. Concepts Nutr."},{"key":"10.1016\/j.ab.2021.114478_bib4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJM198206103062303","article-title":"Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion","volume":"306","author":"Batshaw","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2021.114478_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(80)80416-1","article-title":"Treatment of hyperammonemic coma caused by inborn errors of urea synthesis","volume":"97","author":"Batshaw","year":"1980","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ab.2021.114478_bib6","first-page":"290","article-title":"New approaches to the diagnosis and treatment of inborn errors or urea synthesis","volume":"68","author":"Batshaw","year":"1981","journal-title":"Pediatrics"},{"key":"10.1016\/j.ab.2021.114478_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.6243418","article-title":"Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis","volume":"207","author":"Brusilow","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.ab.2021.114478_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(79)90518-X","article-title":"Arginine therapy of argininosuccinase deficiency","volume":"1","author":"Brusilow","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ab.2021.114478_bib9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM198406213102503","article-title":"Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis","volume":"310","author":"Brusilow","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2021.114478_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0140-6736(79)91503-4","article-title":"New pathways of nitrogen excretion in inborn errors of urea synthesis","volume":"2","author":"Brusilow","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.ab.2021.114478_bib11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1542\/peds.70.4.647","article-title":"Screening for lethal genetic disease","volume":"70","author":"Brusilow","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.ab.2021.114478_bib12","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1067\/mpd.2001.111836","article-title":"Alternative pathway therapy for urea cycle disorders: twenty years later","volume":"138","author":"Batshaw","year":"2001","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ab.2021.114478_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2010.04.008","article-title":"Alternative pathway or diversion therapy for urea cycle disorders now and in the future","volume":"100","author":"Cederbaum","year":"2010","journal-title":"Mol. Genet. Metabol."},{"issue":"Suppl 1","key":"10.1016\/j.ab.2021.114478_bib14","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.ymgme.2010.02.007","article-title":"Nitrogen sparing therapy revisited 2009","volume":"100","author":"Enns","year":"2010","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.ab.2021.114478_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0022-3476(99)70443-9","article-title":"Treatment of urea cycle disorders","volume":"134","author":"Thoene","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ab.2021.114478_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1203\/00006450-199102000-00009","article-title":"Phenylacetylglutamine may replace urea as a vehicle for waste nitrogen excretion","volume":"29","author":"Brusilow","year":"1991","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ab.2021.114478_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-3101(24)00072-0","article-title":"Urea cycle disorders: diagnosis, pathophysiology, and therapy","volume":"43","author":"Brusilow","year":"1996","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.ab.2021.114478_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-3476(05)83044-6","article-title":"Prospective treatment of urea cycle disorders","volume":"119","author":"Maestri","year":"1991","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ab.2021.114478_bib19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(85)91554-5","article-title":"Transient idiopathic hyperammonaemia in adults","volume":"2","author":"Watson","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ab.2021.114478_bib20","first-page":"786","article-title":"Hepatic encephalopathy","volume":"314","author":"Brusilow","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ab.2021.114478_bib21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00005792-200205000-00007","volume":"81","author":"Brusilow","year":"2002","journal-title":"Hyperammonemic encephalopathy, Medicine (Baltimore)"},{"key":"10.1016\/j.ab.2021.114478_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nurt.2010.05.015","article-title":"Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapy","volume":"7","author":"Brusilow","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ab.2021.114478_bib23","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ab.2021.114478_bib24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/SGA.0000000000000376","article-title":"Beyond lactulose: treatment options for hepatic encephalopathy","volume":"42","author":"Said","year":"2019","journal-title":"Gastroenterol. Nurs."},{"key":"10.1016\/j.ab.2021.114478_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOG.0000000000000527","article-title":"Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy","volume":"35","author":"Alsahhar","year":"2019","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.ab.2021.114478_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40265-018-1017-0","article-title":"Hepatic encephalopathy in cirrhosis: pathology and pathophysiology","volume":"79","author":"Butterworth","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ab.2021.114478_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jceh.2018.06.007","article-title":"Hyperammonemia in hepatic encephalopathy","volume":"8","author":"Jayakumar","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ab.2021.114478_bib28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.21357","article-title":"Glutamine: a Trojan horse in ammonia neurotoxicity","volume":"44","author":"Albrecht","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ab.2021.114478_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.neuint.2005.11.017","article-title":"Glutamine in the mechanism of ammonia-induced astrocyte swelling","volume":"48","author":"Jayakumar","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.ab.2021.114478_bib30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11064-012-0955-2","article-title":"Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited","volume":"39","author":"Rama Rao","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ab.2021.114478_bib31","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/bi00831a038","article-title":"Studies on the mechanism of inhibition of glutamine synthetase by methionine sulfoximine","volume":"8","author":"Ronzio","year":"1969","journal-title":"Biochemistry"},{"issue":"Pt 3","key":"10.1016\/j.ab.2021.114478_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj2770697","article-title":"Hyperammonaemia does not impair brain function in the absence of net glutamine synthesis","volume":"277","author":"Hawkins","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.ab.2021.114478_bib33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1471-4159.1993.tb03247.x","article-title":"Effect of reducing brain glutamine synthesis on metabolic symptoms of hepatic encephalopathy","volume":"60","author":"Hawkins","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ab.2021.114478_bib34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00004647-199701000-00006","article-title":"Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia","volume":"17","author":"Sugimoto","year":"1997","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.ab.2021.114478_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cld.2020.01.009","article-title":"Novel therapies in hepatic encephalopathy","volume":"24","author":"Alimirah","year":"2020","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.ab.2021.114478_bib36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jceh.2020.01.001","article-title":"The current hepatic encephalopathy pipeline","volume":"10","author":"Ryu","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ab.2021.114478_bib37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/hep.26611","article-title":"Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy","volume":"59","author":"Rockey","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ab.2021.114478_bib38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.26789","article-title":"Drug-induced removal of nitrogen derivatives in urine: a new concept whose time has come","volume":"59","author":"Cordoba","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.ab.2021.114478_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11011-013-9391-5","article-title":"Ornithine phenylacetate revisited","volume":"28","author":"Jover-Cobos","year":"2013","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ab.2021.114478_bib40","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/bi00834a066","article-title":"Identification of L-methionine S-sulfoximine as the diastereoisomer of L-methionine SR-sulfoximine that inhibits glutamine synthetase","volume":"8","author":"Manning","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2021.114478_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1073\/pnas.66.2.500","article-title":"Identification of L-methionine-S-sulfoximine as the convulsant isomer of methionine sulfoximine","volume":"66","author":"Rowe","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ab.2021.114478_bib42","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1021\/bi00834a065","article-title":"Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate","volume":"8","author":"Rowe","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/j.ab.2021.114478_bib43","doi-asserted-by":"crossref","first-page":"C1101","DOI":"10.1152\/ajpcell.1998.274.4.C1101","article-title":"Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal","volume":"274","author":"Lee","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ab.2021.114478_bib44","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s11011-013-9439-6","article-title":"Inhibition of human glutamine synthetase by L-methionine-S,R-sulfoximine-relevance to the treatment of neurological diseases","volume":"29","author":"Jeitner","year":"2014","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ab.2021.114478_bib45","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3748\/wjg.v26.i18.2221","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care","volume":"26","author":"Bohra","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ab.2021.114478_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0021-9258(19)77779-5","article-title":"Studies of the biological effects of methionine sulfoximine","volume":"192","author":"Gershoff","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ab.2021.114478_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1152\/jappl.1949.1.11.802","article-title":"Species specificity of agene toxicity","volume":"1","author":"Pollock","year":"1949","journal-title":"J. Appl. Physiol."}],"container-title":["Analytical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269721003791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003269721003791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T21:34:40Z","timestamp":1757712880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003269721003791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":47,"alternative-id":["S0003269721003791"],"URL":"https:\/\/doi.org\/10.1016\/j.ab.2021.114478","relation":{},"ISSN":["0003-2697"],"issn-type":[{"value":"0003-2697","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saul Brusilow: Understanding and treating diseases of ammonia toxicity","name":"articletitle","label":"Article Title"},{"value":"Analytical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ab.2021.114478","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114478"}}